Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.
作者信息
Bruneton J N, Falewee M N, Balu-Maestro C, Normand F, Mattrey R F
机构信息
Department of Radiology, Centre Antoine, Lacassagne, Nice, France.
出版信息
Invest Radiol. 1988 Sep;23 Suppl 1:S306-7.
PMID:3198367
Abstract
The preliminary results of perfluorocytlbromide (PFOB) emulsion when used as an intravenous contrast agent for hepatosplenic CT imaging in humans are reported. Ten patients were examined using dosages ranging from 1 to 2 g/kg. There was good clinical and biochemical tolerance. Diagnostic dose for liver enhancement seems to be at least 2 g/kg, whereas 1 g/kg was sufficient for splenic enhancement.
摘要
Zotero 插件